Stocks · Healthcare · Medical - Care Facilities
biote Corp. BTMD
$1.15 -0.86% Close, Oct 2, 2026 · NASDAQ · Market cap $50.7M
High qualityWeak trendInexpensive vs sectorHigh risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.12, down 87.0% year over year.
- The diluted share count fell 22.5% in a year, mainly through buybacks.
- Operating margin narrowed to 8.0% from 17.8% a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 20%
- EPS growth (TTM, YoY)Bottom 19%
- FCF growth (TTM, YoY)Bottom 18%
- Revenue growth, 3-year CAGRBottom 38%
- Revenue growth accelerationBottom 35%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 10%
- Gross marginBottom 46%
- Operating marginTop 30%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 16%
- Net debt / EBITDA (lower is better)Bottom 13%
- Interest coverTop 38%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 3%
- Free-cash-flow yieldTop 1%
- EBITDA / enterprise valueTop 5%
- Sales / enterprise valueTop 8%
- P/E vs own 5-year history (lower is better)Bottom 28%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 9%
- 6-month returnBottom 18%
- 1-year return vs S&P 500Bottom 6%
- Distance from 52-week highBottom 12%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 34%
- Upside to consensus price targetTop 14%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 10%
- Maximum drawdown, 3 yearsBottom 23%
- Beta vs S&P 500 (lower is better)Bottom 37%
- Net debt / EBITDA (lower is better)Bottom 13%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -5.6% | -7.8% | ↓ |
| EPS growth (YoY) | -26.7% | -87.0% | ↓ |
| Gross margin | 71.9% | 60.2% | ↓ |
| Operating margin | 17.8% | 8.0% | ↓ |
| FCF margin | 17.6% | 10.7% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -7.8% | -5.6% | ↓ | Bottom 20% |
| EPS growth (TTM, YoY) | -87.0% | -26.7% | ↓ | Bottom 19% |
| Gross margin | 60.2% | 71.9% | ↓ | Bottom 46% |
| Operating margin | 8.0% | 17.8% | ↓ | Top 30% |
| Net margin | 3.2% | 15.7% | ↓ | — |
| Free-cash-flow margin | 10.7% | 17.6% | ↓ | — |
| Return on invested capital | 13.5% | — | Top 10% | |
| Revenue growth, 3-year CAGR | 5.2% | — | Bottom 38% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -18.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -7.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 5.01×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 1.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.29%
- Net buyback yield (TTM)
- 17.96%
- Shareholder yield
- 18.25%
- Share count change, 1 year
- -22.5%
- Share count change, 3-year CAGR
- +11.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -1.3%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $4.00
- Target vs current price
- +247.8%
- Analysts with a rating
- 7
- Share rating Buy or Strong Buy
- 86%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | -962.4% | -0.4% | -32.2% | -26.4% | — |
| May 6, 2026 | -33.3% | -0.5% | -0.5% | -4.5% | +1.8% |
| Mar 11, 2026 | +20.0% | +1.2% | -20.0% | -13.5% | +38.8% |
| Nov 5, 2025 | +340.0% | +2.4% | -8.7% | -9.8% | -20.6% |
| Aug 6, 2025 | +66.7% | -7.4% | -30.7% | -16.3% | -36.0% |
| May 7, 2025 | +33.3% | -0.9% | +16.0% | +5.0% | +15.4% |
| Mar 12, 2025 | +11.1% | -0.7% | -1.5% | -21.3% | -11.1% |
| Nov 12, 2024 | +266.7% | -4.0% | +7.1% | +17.4% | -16.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.23 | $0.03 | -962.4% | $44.2M |
| May 6, 2026 | $0.06 | $0.09 | -33.3% | $44.9M |
| Mar 11, 2026 | $0.06 | $0.05 | +20.0% | $46.4M |
| Nov 5, 2025 | $0.22 | $0.05 | +340.0% | $48.0M |
| Aug 6, 2025 | $0.10 | $0.06 | +66.7% | $48.9M |
| May 7, 2025 | $0.08 | $0.06 | +33.3% | $49.0M |
| Mar 12, 2025 | $0.10 | $0.09 | +11.1% | $49.8M |
| Nov 12, 2024 | $0.33 | $0.09 | +266.7% | $51.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 9.9× | 3.4× | 67th | Top 3% |
| P/E (forward) | 41.8× | — | — | — |
| EV / EBITDA | 7.2× | — | — | Top 5% |
| EV / Sales | 0.92× | — | — | Top 8% |
| Free-cash-flow yield | 38.80% | — | — | Top 1% |
| Earnings yield | 10.15% | — | — | Top 3% |
P/E over the past five years
Range 1.6× – 121.9× since Sep 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -61.4%
- Earnings per share growth (TTM)
- -87.0%
- Change in P/E multiple
- +296.3%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -18.3%
- 200-day average slope (20 days)
- -6.1%
- Distance from 50-day average
- -26.9%
- Distance from 200-day average
- -41.8%
- RSI (14)
- 28.6
- Relative volume
- 1.00×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 97.0%
- Volatility vs own 5-year history
- 88th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.37
- Correlation with S&P 500
- 0.30
- Current drawdown from 1-year high
- -63.9%
- Maximum drawdown, 3 years
- -86.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| May 13, 2021 | Oct 2, 2026 | -88.6% | 1353 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $50.7M
- P/E (TTM)
- 9.9
- EPS, diluted (TTM)
- $0.12
- Revenue (TTM)
- $183.5M
- 52-week range
- $1.15 – $3.26
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $139.4M | $165.0M | $185.4M | $197.2M | $192.2M |
| Gross profit | $90.6M | $110.4M | $127.5M | $139.1M | $137.4M |
| Operating income | $34.6M | -$60.7M | $28.7M | $31.6M | $35.6M |
| Net income | $32.6M | -$969,000 | $3.3M | $3.2M | $27.0M |
| EPS (diluted) | $4.31 | -$0.12 | $0.13 | $0.09 | $0.74 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $51.4M | $49.8M | $49.0M | $48.9M | $48.0M | $46.4M | $44.9M | $44.2M |
| Net income | $10.7M | $3.7M | $13.7M | $3.2M | $8.2M | $2.0M | $2.3M | -$6.6M |
| EPS (diluted) | $0.33 | $0.10 | $0.37 | $0.10 | $0.22 | $0.06 | $0.06 | -$0.23 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $33.7M | -$9.2M | $26.9M | $45.2M | $35.2M |
| Capital expenditure | -$3.8M | -$1.8M | -$2.7M | -$6.4M | -$5.0M |
| Free cash flow | $29.9M | -$11.0M | $24.2M | $38.8M | $30.2M |
| Dividends paid | -$11.4M | -$12.9M | -$8.7M | -$4.7M | -$1.7M |
| Net share buybacks | $0 | $18,000 | $144,000 | -$5.3M | -$3.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $11.2M
- Total assets
- $101.7M
- Total liabilities
- $159.9M
- Total debt
- $128.6M
- Net debt
- $117.5M
- Shareholders’ equity
- -$65.8M
As of Jun 30, 2026 (filed Aug 7, 2026).
Short interest
- Shares sold short
- 1,280,901
- Days to cover
- 5.18
- Change vs previous report
- -8.2%
FINRA short interest, settlement date Sep 15, 2026.